Participate in a Clinical Trial

Without the participation of people with MS, it would be impossible to develop new and better therapies and other interventions.

Clinical Trials in MS

The latest clinical research in MS, including trials funded by the Society and trials in progressive MS.

NARCOMS Patient Registry

Register as a willing MS research participant to facilitate multicenter studies. Initiated by the Consortium of MS Centers.

Visit NARCOMS

Posting a Trial

If you would like us to post a study on these pages, please email studies@nmss.org to find out what information you need to submit for review.

Clinical Trials In Your Area

Interested in clinical trials? Simply search by state, type of MS or keyword and see what’s going on in your area.

Clinical Trial: Ofatumumab

12-week study for treatment of Relapsing MS, followed by a 4.5-year extension study. Qualifying participants will receive study medication and study related exams at no cost. Compensation will be provided for time and travel costs. To qualify: Must be between 18-55 year...

Get Details
Clinical Trial: ADS-5102 (amantadine extended release [ER] capsules)

The INROADS study is now enrolling volunteers to help test an investigational study drug for people with MS who have trouble walking. Researchers want to learn if the investigational medication may help improve walking and become a future treatment option. If you qualify and ...

Get Details
Clinical Trial: Biomarker-Guided Combination Therapies for MS

In people with MS, brain and cerebrospinal fluid biomarkers indicate inflammation or disease. Researchers at the National Institutes Health (NIH) seek volunteers with MS to see if 4 therapies given alone or combined affect MS biomarkers. They want to see if a change in biomark...

Get Details
Clinical Trial: ReCOVER – Clemastine Fumarate in Optic Neuritis

WE ARE ACTIVELY RECRUITING PEOPLE EXPERIENCING A SUSPECTED OR DIAGNOSED ACUTE OPTIC NEURITIS IN AN EYE NOT PREVIOUSLY AFFECTED AND HAS YET TO RECEIVE STEROID TREATMENT FOR. ReCOVER aims to assess the effect of clemastine as a myelin repair agent and its potential for th...

Get Details
Clinical Trial: Linking Cognitive Functioning to Multimodal Imaging in Multiple Sclerosis

This project studies the link between performance on sensitive computer-based measures of cognitive functioning (games that test reaction time) and findings on neuroimaging (brain scans with MRI and PET) for people who are new to receiving Tecfidera to manage their MS. At the...

Get Details
Clinical Trial: Virtual Reality for MS

Researchers are looking at the impact of virtual reality on walking for individuals with relapse and remitting Multiple Sclerosis. The intervention group will receive 18 sessions of Treadmill Training with Virtual Reality and the active control comparison will receive 18 tr...

Get Details
Clinical Trial: Virtual Reality to Improve Quality of Life

Participants with MS and other neurological disorders will be recruited to complete sessions of virtual reality (VR) viewing and game playing. VR has been shown to have therapeutic benefit in certain patient populations and requires further clinical study to determine the exte...

Get Details
Clinical Trials: Transcranial Direct Current Stimulation Studies

Researchers at New York University are recruiting people with MS for three studies involving transcranial direct current stimulation (tDCS, which involves low electrical current delivered via electrodes). Clinical Trial: A Pilot Trial of Remotely-Supervised Transcranial Dire...

Get Details
Clinical Trial: Tracking Health in Multiple Sclerosis (TracMS)

In Trac-MS researchers are interested in learning more about the relationship between everyday behaviors, thinking abilities, and brain health in people with relapsing-remitting multiple sclerosis and cognitive impairment, ages 30-59. Specifically, they are interested in exami...

Get Details
Clinical Trial: Ketamine for MS-related fatigue

Potential participants will come in to Johns Hopkins University for one visit. After signing the informed consent form and assessment of eligibility, participants will be randomly assigned to receive ketamine (12 participants) or midazolam (6 participants). They will receive o...

Get Details

|< < 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 - 11 > >|

Learn About Clinical Trials

Participating in Clinical Trials

What you need to know about clinical trial participation.

Download the Guide

Discover More

Here are a few related topics that may interest you

The National MS Society is Here to Help

Need More Information?

We Are Here

Our MS Navigators help identify solutions and provide access to the resources you are looking for. Call 1-800-344-4867 or contact us online.

Newly Diagnosed

If you or somone close to you has recently been diagnosed, access our MS information and resources.

Start Here

Participate in a Clinical Trial

Clinical Trials in MS

NARCOMS Patient Registry

Posting a Trial

Share

Clinical Trials In Your Area

Clinical Trial: Ofatumumab

Clinical Trial: ADS-5102 (amantadine extended release [ER] capsules)

Clinical Trial: Biomarker-Guided Combination Therapies for MS

Clinical Trial: ReCOVER – Clemastine Fumarate in Optic Neuritis

Clinical Trial: Linking Cognitive Functioning to Multimodal Imaging in Multiple Sclerosis

Clinical Trial: Virtual Reality for MS

Clinical Trial: Virtual Reality to Improve Quality of Life

Clinical Trials: Transcranial Direct Current Stimulation Studies

Clinical Trial: Tracking Health in Multiple Sclerosis (TracMS)

Clinical Trial: Ketamine for MS-related fatigue

Share

Learn About Clinical Trials

Discover More

The National MS Society is Here to Help

We Are Here